Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor
暂无分享,去创建一个
J. Auwerx | D. Mangelsdorf | J. Repa | M. D. Leibowitz | J. Lobaccaro | G. Torpier | A. Tailleux | C. Fiévet | R. Heyman | J. Paterniti | T. Claudel | B. Wagner
[1] Christopher K. Glass,et al. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.
[2] V. Pasceri,et al. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. , 2000, Circulation.
[3] C. Glass,et al. Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein , 1998 .
[4] D. Rader,et al. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[5] Andrew C. Li,et al. Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice , 2000 .
[6] M. Cantorna,et al. In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. , 1994, Journal of immunology.
[7] E. Olson,et al. Retinoid receptor expression and all-trans retinoic acid-mediated growth inhibition in vascular smooth muscle cells. , 1996, Circulation.
[8] R. Evans,et al. Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.
[9] R. Eckel,et al. Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity. , 2001, Molecular pharmacology.
[10] P. Libby,et al. Macrophages in Human Atheroma Contain PPARγ: Differentiation-Dependent Peroxisomal Proliferator-Activated Receptor γ (PPARγ) Expression and Reduction of MMP-9 Activity through PPARγ Activation in Mononuclear Phagocytes in Vitro , 1998 .
[11] A. Tall,et al. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. , 2000, The Journal of biological chemistry.
[12] L. Hamann,et al. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists , 1997, Nature.
[13] N. Maeda,et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.
[14] R. Ross,et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[15] D. Mangelsdorf,et al. Human White/Murine ABC8 mRNA Levels Are Highly Induced in Lipid-loaded Macrophages , 2000, The Journal of Biological Chemistry.
[16] P. Libby,et al. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. , 1998, Circulation research.
[17] R. Hammer,et al. Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRα , 1998, Cell.
[18] J. Qiao,et al. Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[19] J. Auwerx,et al. Alterations in Lipoprotein Metabolism in Peroxisome Proliferator-activated Receptor α-deficient Mice* , 1997, The Journal of Biological Chemistry.
[20] Philippe Kastner,et al. Nonsteroid nuclear receptors: What Are genetic studies telling us about their role in real life? , 1995, Cell.
[21] E. Rubin,et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.
[22] P. Colville-Nash,et al. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. , 1998, Journal of immunology.
[23] A. Rigotti,et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[24] R. Evans,et al. PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.
[25] J Auwerx,et al. PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene. , 1996, The EMBO journal.
[26] D. Mangelsdorf,et al. Nuclear receptor regulation of cholesterol and bile acid metabolism. , 1999, Current opinion in biotechnology.
[27] M. Wilkins,et al. Inhibition of nitric oxide synthesis in vascular smooth muscle by retinoids , 1994, British journal of pharmacology.
[28] B. Aggarwal,et al. Inhibition by all‐trans‐retinoic acid of tumor necrosis factor and nitric oxide production by peritoneal macrophages , 1994, Journal of leukocyte biology.
[29] W. Miller,et al. Induction of apoptosis without differentiation by retinoic acid in PLB-985 cells requires the activation of both RAR and RXR. , 1997, Blood.
[30] N. Maeda,et al. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[31] E. Edelman,et al. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels , 1997, Nature.
[32] R. Sampliner,et al. The effects of 13‐cis‐retinoic acid and beta‐carotene on cellular immunity in humans , 1991, Cancer.
[33] D. Mangelsdorf,et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. , 2000, Science.
[34] R. Evans,et al. The RXR heterodimers and orphan receptors , 1995, Cell.
[35] S. Tanaka,et al. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes. , 1998, The Journal of clinical endocrinology and metabolism.
[36] B. Seed,et al. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines , 1998, Nature.
[37] W. Wahli,et al. The PPARα–leukotriene B4 pathway to inflammation control , 1996, Nature.
[38] Y. Takahashi,et al. Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.